Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article. IJRMCS [Internet]. 2024 Jul. 1 [cited 2026 Oct. 21];2(02):20-3. Available from: https://www.journalserapublications.com/index.php/ijrmcs/article/view/7